MedTrace Logo

Detecting Bladder Cancer Using the UroMark Test.

NCT02676180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3700

Last updated 2023-12-08

No results posted yet for this study

Summary

DETECT I is a prospective multicentre observational diagnostic study to assess the performance of the UroMark assay to rule out bladder cancer in patients with haematuria. The study will recruit consecutive patients attending haematuria clinics as well as patients referred to urology outpatient clinics for investigation of haematuria. Consenting patients will be provided with a urine sample collection kit and asked to provide a urine sample. An additional urine sample for control assay testing will be provided after the clinic attendance.

Conditions

Interventions

OTHER

Group

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • John Kelly, FRCS (urol) · UCL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02676180 on ClinicalTrials.gov